1. Department of Pulmonary Medicine, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turquía;2. Department of Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turquía
Abstract:
Hemoptysis is symptomatic of potentially serious and life-threatening chest disease and requires urgent evaluation and treatment. The aim of this study was to evaluate the hemostatic efficacy of endobronchial application of Ankaferd Blood Stopper® (ABS) solution in patients with hemoptysis.